A detailed history of Schonfeld Strategic Advisors LLC transactions in Mannkind Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,237,962 shares of MNKD stock, worth $8.69 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,237,962
Previous 474,019 161.16%
Holding current value
$8.69 Million
Previous $2.47 Million 214.23%
% of portfolio
0.06%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $3.83 Million - $5.12 Million
763,943 Added 161.16%
1,237,962 $7.77 Million
Q2 2024

Aug 14, 2024

SELL
$4.05 - $5.43 $1.77 Million - $2.37 Million
-436,977 Reduced 47.97%
474,019 $2.47 Million
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $337,649 - $547,510
-103,892 Reduced 10.24%
910,996 $4.13 Million
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $139,237 - $178,841
41,688 Added 4.28%
1,014,888 $3.69 Million
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $348,009 - $485,077
89,005 Added 10.07%
973,200 $4.02 Million
Q2 2023

Aug 14, 2023

BUY
$3.72 - $4.79 $138,313 - $178,096
37,181 Added 4.39%
884,195 $3.6 Million
Q1 2023

May 15, 2023

SELL
$3.95 - $5.63 $7.96 Million - $11.3 Million
-2,015,886 Reduced 70.41%
847,014 $3.47 Million
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $252,677 - $449,297
83,668 Added 3.01%
2,862,900 $15.1 Million
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $1.02 Million - $1.49 Million
341,603 Added 14.01%
2,779,232 $8.59 Million
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $2.85 Million - $5.09 Million
1,067,829 Added 77.96%
2,437,629 $9.29 Million
Q1 2022

May 16, 2022

BUY
$2.62 - $4.45 $61,308 - $104,130
23,400 Added 1.74%
1,369,800 $5.04 Million
Q4 2021

Feb 14, 2022

BUY
$4.05 - $5.37 $692,550 - $918,270
171,000 Added 14.55%
1,346,400 $5.88 Million
Q3 2021

Nov 16, 2021

SELL
$3.89 - $5.48 $4.79 Million - $6.74 Million
-1,230,400 Reduced 51.14%
1,175,400 $5.11 Million
Q2 2021

Aug 16, 2021

BUY
$3.61 - $5.45 $3.66 Million - $5.52 Million
1,013,689 Added 72.82%
2,405,800 $13.1 Million
Q1 2021

May 17, 2021

BUY
$3.14 - $6.14 $4.2 Million - $8.21 Million
1,336,983 Added 2425.23%
1,392,111 $5.46 Million
Q4 2020

Feb 16, 2021

SELL
$1.79 - $4.04 $258,962 - $584,474
-144,672 Reduced 72.41%
55,128 $173,000
Q3 2020

Nov 16, 2020

SELL
$1.56 - $2.08 $141,024 - $188,032
-90,400 Reduced 31.15%
199,800 $0
Q2 2020

Aug 14, 2020

BUY
$0.94 - $2.21 $272,788 - $641,342
290,200 New
290,200 $508,000
Q1 2020

May 15, 2020

SELL
$0.84 - $1.76 $33,852 - $70,928
-40,300 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$1.14 - $1.49 $697,793 - $912,029
-612,100 Reduced 93.82%
40,300 $52,000
Q3 2019

Nov 14, 2019

BUY
$1.04 - $1.44 $678,496 - $939,456
652,400 New
652,400 $815,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.